{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T04:03:18Z","timestamp":1770436998637,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,3,15]],"date-time":"2014-03-15T00:00:00Z","timestamp":1394841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,3,15]],"date-time":"2014-03-15T00:00:00Z","timestamp":1394841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Sleep Med"],"published-print":{"date-parts":[[2014,3,15]]},"DOI":"10.5664\/jcsm.3524","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T14:32:39Z","timestamp":1394807559000},"page":"263-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Impact of OSA on Biological Markers in Morbid Obesity and Metabolic Syndrome"],"prefix":"10.1007","volume":"10","author":[{"given":"Neus","family":"Salord","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merc\u00e8","family":"Gasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Mayos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria","family":"Fortuna-Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep Maria","family":"Montserrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"S\u00e1nchez-de-la-Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Barcel\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferran","family":"Barb\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Vilarrasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Monasterio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,15]]},"reference":[{"key":"1003005_CR1","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International association for the Study of Obesity. Circulation 2009;120:1640\u20135.","journal-title":"Circulation"},{"key":"1003005_CR2","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2337\/diacare.28.7.1769","volume":"28","author":"ES Ford","year":"2005","unstructured":"Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769\u201378.","journal-title":"Diabetes Care"},{"key":"1003005_CR3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1440-1843.2011.02081.x","volume":"17","author":"JC Lam","year":"2012","unstructured":"Lam JC, Mak JC, Ip MS. Obesity, obstructive sleep apnoea and metabolic syndrome. Respirology 2012;17:223\u201336.","journal-title":"Respirology"},{"key":"1003005_CR4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1183\/09031936.00198810","volume":"38","author":"M Gasa","year":"2011","unstructured":"Gasa M, Salord N, Fortuna AM, et al. Obstructive sleep apnea and metabolic impairment in severe obesity. Eur Respir J 2011;38:1089\u201397.","journal-title":"Eur Respir J"},{"key":"1003005_CR5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/sleep\/32.4.447","volume":"32","author":"ES Arnardottir","year":"2009","unstructured":"Arnardottir ES, Mackiewick M, Gislason T, Teff KL, Pack A. Molecular signatures of obstructive sleep apnea in adults: A review and perspective. Sleep 2009;32:447\u201370.","journal-title":"Sleep"},{"key":"1003005_CR6","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1183\/09031936.00047010","volume":"39","author":"MR Bonsignore","year":"2012","unstructured":"Bonsignore MR, McNicholas WT, Montserrat JM, Eckel J. Adipose tissue in obesity and obstructive sleep apnoea. Eur Respir J 2012;39:746\u201367.","journal-title":"Eur Respir J"},{"key":"1003005_CR7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.tem.2010.08.001","volume":"21","author":"MC Ernst","year":"2010","unstructured":"Ernst MC, Sinal CJ. Chemerin. at the crossroads of inflammation and obesity. Trends Endocrinol Metab 2010;21:660\u20137.","journal-title":"Trends Endocrinol Metab"},{"key":"1003005_CR8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/CIRCULATIONAHA.107.743062","volume":"117","author":"GA Rosito","year":"2008","unstructured":"Rosito GA, Massaro JM, Hoffmann U, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008;117:605\u201313.","journal-title":"Circulation"},{"key":"1003005_CR9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1177\/193229680800200623","volume":"2","author":"DL Duren","year":"2008","unstructured":"Duren DL, Sherwood RJ, Czerwinski SA, et al. Body composition methods: comparisons and interpretation. J Diabetes Sci Technol 2008;2:1139\u201346.","journal-title":"J Diabetes Sci Technol"},{"key":"1003005_CR10","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s001250051503","volume":"43","author":"A Pascot","year":"2000","unstructured":"Pascot A, Despr\u00e9s JP, Lemieux I, et al. Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance. Diabetologia 2000;43:1126\u201335.","journal-title":"Diabetologia"},{"key":"1003005_CR11","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1183\/09031936.00050410","volume":"37","author":"A Barcel\u00f3","year":"2011","unstructured":"Barcel\u00f3 A, Pi\u00e9rola J, de la Pe\u00f1a M, et al. Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea. Eur Respir J 2011;37:1418\u201323.","journal-title":"Eur Respir J"},{"key":"1003005_CR12","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/sleep\/33.9.1193","volume":"33","author":"IC Trombetta","year":"2010","unstructured":"Trombetta IC, Somers VK, Maki-Nunes C, et al. Consequences of comorbid sleep apnea in the metabolic syndrome implications for cardiovascular risk. Sleep 2010;33:1193\u20139.","journal-title":"Sleep"},{"key":"1003005_CR13","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.06-1807","volume":"131","author":"M Kono","year":"2007","unstructured":"Kono M, Tatsumi K, Saibara T, et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007;131:1387\u201392.","journal-title":"Chest"},{"key":"1003005_CR14","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1378\/chest.08-1798","volume":"135","author":"MM Lui","year":"2009","unstructured":"Lui MM, Lam JC, Mak HK, et al. C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest 2009;135:950\u20136.","journal-title":"Chest"},{"key":"1003005_CR15","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1210\/jc.2005-0482","volume":"90","author":"AD Karelis","year":"2005","unstructured":"Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90:4145\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"1003005_CR16","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1210\/jc.2007-2724","volume":"93","author":"CA Aguilar-Salinas","year":"2008","unstructured":"Aguilar-Salinas CA, Garc\u00eda EG, Robles L, et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. Clin Endocrinol Metab 2008;93:4075\u20139.","journal-title":"Clin Endocrinol Metab"},{"key":"1003005_CR17","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1210\/jc.2004-0165","volume":"89","author":"AD Karelis","year":"2004","unstructured":"Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89:2569\u201375.","journal-title":"J Clin Endocrinol Metab"},{"key":"1003005_CR18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11695-009-9999-z","volume":"20","author":"V Soverini","year":"2010","unstructured":"Soverini V, Moscatiello S, Villanova N, Ragni E, Di Domizio S, Marchesini G. Metabolic syndrome and insulin resistance in subjects with morbid obesity. Obes Surg 2010;20:295\u2013301.","journal-title":"Obes Surg"},{"key":"1003005_CR19","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/diacare.23.12.1835","volume":"23","author":"M Frohlich","year":"2000","unstructured":"Frohlich M, Imhof A, Berg G, et al. Association between C-reactive protein and features of the metabolic syndrome a population-based study. Diabetes Care 2000;23:1835\u20139.","journal-title":"Diabetes Care"},{"key":"1003005_CR20","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/01.CIR.0000125690.80303.A8","volume":"109","author":"PM Ridker","year":"2004","unstructured":"Ridker PM, Coo N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores. Circulation 2004;109:1955\u20139.","journal-title":"Circulation"},{"key":"1003005_CR21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1164\/rccm.200412-1652OC","volume":"172","author":"K Minoguchi","year":"2005","unstructured":"Minoguchi K, Yokoe T, Tazaki T, et al. Increased carotid intima media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 2005;172:625\u201330.","journal-title":"Am J Respir Crit Care Med"},{"key":"1003005_CR22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1378\/chest.129.2.233","volume":"129","author":"M Can","year":"2006","unstructured":"Can M, A\u00e7ikg\u00f6z S, Mungan G, et al. Serum cardiovascular risk factors in obstructive sleep apnea. Chest 2006;129:233\u20137.","journal-title":"Chest"},{"key":"1003005_CR23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/thx.2006.066720","volume":"62","author":"S Ryan","year":"2007","unstructured":"Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C. McNycolas WT. Cardiovascular risk markers in obstructive sleep apnea syndrome and correlation with obesity. Thorax 2007;62:509\u201314.","journal-title":"Thorax"},{"key":"1003005_CR24","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/sleep\/30.8.991","volume":"30","author":"S Taheri","year":"2007","unstructured":"Taheri S, Austin D, Lin L, Nieto F J, Young T, Mignot E. Correlates of serum C-reactive protein (CRP) - no association with sleep duration or sleep disordered breathing. Sleep 2007;30:991\u20136.","journal-title":"Sleep"},{"key":"1003005_CR25","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1056\/NEJMp038114","volume":"349","author":"J Korner","year":"2003","unstructured":"Korner J, Leibel RL. To eat or not to eat - how the gut talks to the brain. N Engl J Med 2003;349:926\u20138.","journal-title":"N Engl J Med"},{"key":"1003005_CR26","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1097\/HJH.0b013e3281afa09e","volume":"25","author":"F Galletiti","year":"2007","unstructured":"Galletiti F, Barbato A, Vesiero M, et al. Circulating Leptin levels predict the development of metabolic syndrome in middle-aged men: An 8-year follow-up study. J Hypertens 2007;25:1671\u20137.","journal-title":"J Hypertens"},{"key":"1003005_CR27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/jcem.85.3.6484","volume":"85","author":"AN Vogontzas","year":"2000","unstructured":"Vogontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance and hypercytokinemia. J Clin Endocrinol Metab 2000;85:1151\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1003005_CR28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","volume":"115","author":"G Fantuzzi","year":"2005","unstructured":"Fantuzzi G. Molecular mechanisms in allergy and clinical immunology. J Allergy Clin Immunol 2005;115:911\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"1003005_CR29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/oby.2005.24","volume":"13","author":"R Wolk","year":"2005","unstructured":"Wolk R, Svatikova A, Nelson CA, et al. Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obesity 2005;13:186\u201390.","journal-title":"Obesity"},{"key":"1003005_CR30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2265.2005.02407.x","volume":"64","author":"S Makino","year":"2006","unstructured":"Makino S, Handa H, Suzukawa K, et al. Obstructive sleep apnea syndrome, plasma adiponectin levels and insulin resistance. Clin Edocrinol 2006;64:12\u20139.","journal-title":"Clin Edocrinol"},{"key":"1003005_CR31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2265.2009.03664.x","volume":"72","author":"J Weigert","year":"2010","unstructured":"Weigert J, Neumeier M, Wanninger J, et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol 2010;72:342\u20138.","journal-title":"Clin Endocrinol"},{"key":"1003005_CR32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3109\/1354750X.2012.658864","volume":"17","author":"X Feng","year":"2012","unstructured":"Feng X, Li P, Zhou C, Jia X, Kang J. Elevated levels of serum chemerin in patients with obstructive sleep apnea syndrome. Biomarkers 2012;17:248\u201353.","journal-title":"Biomarkers"},{"key":"1003005_CR33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrcardio.2010.145","volume":"7","author":"M Kohler","year":"2010","unstructured":"Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 2010;7:677\u201385.","journal-title":"Nat Rev Cardiol"},{"key":"1003005_CR34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000096835","volume":"74","author":"EP Cherniack","year":"2007","unstructured":"Cherniack EP. Vascular endothelial growth factor and sleep apnea: clutching at straws in the night. Respiration 2007;74:17\u20138.","journal-title":"Respiration"},{"key":"1003005_CR35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000109643","volume":"76","author":"M De la Pe\u00f1a","year":"2008","unstructured":"De la Pe\u00f1a M, Barcel\u00f3 A, Barbe F, et al. Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome. Respiration 2008;76:28\u201332.","journal-title":"Respiration"},{"key":"1003005_CR36","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood.V98.4.1255","volume":"98","author":"S Imagawa","year":"2001","unstructured":"Imagawa S, Yamaguchi Y, Higuchi M, et al. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood 2001;98:1255\u20137.","journal-title":"Blood"},{"key":"1003005_CR37","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1161\/01.CIR.0000089093.75585.98","volume":"108","author":"PE Szmitko","year":"2003","unstructured":"Szmitko PE, Wang CH, Weisel RD, Jeffries GA, Anderson TJ, Verma S. Biomarkers of vascular disease linking inflammation to endothelial activation: Part II. Circulation 2003;108:2041\u20138.","journal-title":"Circulation"},{"key":"1003005_CR38","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1164\/rccm.200703-500OC","volume":"176","author":"LF Drager","year":"2007","unstructured":"Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007;176:706\u201312.","journal-title":"Am J Respir Crit Care Med"},{"key":"1003005_CR39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1164\/rccm.201106-0964OC","volume":"184","author":"M Kohler","year":"2011","unstructured":"Kohler M, Stoewhas AC, Ayers L, Senn O, et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 2011;184:92\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"1003005_CR40","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/thoraxjnl-2011-201420","volume":"67","author":"CM Hoyos","year":"2012","unstructured":"Hoyos CM, Killick R, Yee BJ, Phillips CL, Grunstein RR, Liu PY. Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study. Thorax 2012;67:1081\u20139.","journal-title":"Thorax"},{"key":"1003005_CR41","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/thx.2006.074351","volume":"62","author":"SD West","year":"2007","unstructured":"West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007;62:969\u201374.","journal-title":"Thorax"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.5664\/jcsm.3524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.3524\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.aasmnet.org\/jcsm\/viewabstract.aspx?pid=29375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.5664\/jcsm.3524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:09:08Z","timestamp":1770365348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.5664\/jcsm.3524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,15]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3,15]]}},"alternative-id":["1003005"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.3524","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,15]]},"assertion":[{"value":"1 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}